189 related articles for article (PubMed ID: 9058411)
41. In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
Kung MP; Kung HF; Chumpradit S; Foulon C
Eur J Pharmacol; 1993 Apr; 235(1):165-6. PubMed ID: 8519278
[TBL] [Abstract][Full Text] [Related]
42. Alterations in dopamine D3 receptors in the circling (ci3) rat mutant.
Schirmer M; Nobrega JN; Harrison SJ; Löscher W
Neuroscience; 2007 Feb; 144(4):1462-9. PubMed ID: 17187934
[TBL] [Abstract][Full Text] [Related]
43. Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiographic study.
Schotte A; Janssen PF; Bonaventure P; Leysen JE
Histochem J; 1996 Nov; 28(11):791-9. PubMed ID: 8968731
[TBL] [Abstract][Full Text] [Related]
44. Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain.
Mengod G; Villaró MT; Landwehrmeyer GB; Martinez-Mir MI; Niznik HB; Sunahara RK; Seeman P; O'Dowd BF; Probst A; Palacios JM
Neurochem Int; 1992 Mar; 20 Suppl():33S-43S. PubMed ID: 1365451
[TBL] [Abstract][Full Text] [Related]
45. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
[TBL] [Abstract][Full Text] [Related]
46. Dopamine D3 receptor binding by D3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography.
Kaichi Y; Nonaka R; Hagino Y; Watanabe M
Can J Physiol Pharmacol; 2000 Jan; 78(1):7-11. PubMed ID: 10741754
[TBL] [Abstract][Full Text] [Related]
47. Tyrosine-induced release of dopamine is under inhibitory control of presynaptic dopamine D2 and, probably, D3 receptors in the dorsal striatum, but not in the nucleus accumbens.
Fusa K; Saigusa T; Koshikawa N; Cools AR
Eur J Pharmacol; 2002 Jul; 448(2-3):143-50. PubMed ID: 12144934
[TBL] [Abstract][Full Text] [Related]
48. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
49. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
50. Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics.
Hurley MJ; Stubbs CM; Jenner P; Marsden CD
Eur J Pharmacol; 1996 Dec; 318(2-3):283-93. PubMed ID: 9016916
[TBL] [Abstract][Full Text] [Related]
51. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
Rogoz R; Dziedzicka-Wasylewska M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304
[TBL] [Abstract][Full Text] [Related]
52. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Chumpradit S; Kung MP; Vessotskie J; Foulon C; Mu M; Kung HF
J Med Chem; 1994 Nov; 37(24):4245-50. PubMed ID: 7990123
[TBL] [Abstract][Full Text] [Related]
53. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
Roberts C; Cummins R; Gnoffo Z; Kew JN
Eur J Pharmacol; 2006 Mar; 534(1-3):108-14. PubMed ID: 16490190
[TBL] [Abstract][Full Text] [Related]
54. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
[TBL] [Abstract][Full Text] [Related]
55. Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.
Bancroft GN; Morgan KA; Flietstra RJ; Levant B
Neuropsychopharmacology; 1998 Apr; 18(4):305-16. PubMed ID: 9509498
[TBL] [Abstract][Full Text] [Related]
56. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
Ryoo HL; Pierrotti D; Joyce JN
Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147
[TBL] [Abstract][Full Text] [Related]
57. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats.
Yamada S; Yokoo H; Nishi S
Brain Res; 1994 Jun; 648(1):176-9. PubMed ID: 7922522
[TBL] [Abstract][Full Text] [Related]
58. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
Leysen JE; Gommeren W; Mertens J; Luyten WH; Pauwels PJ; Ewert M; Seeburg P
Psychopharmacology (Berl); 1993; 110(1-2):27-36. PubMed ID: 7870895
[TBL] [Abstract][Full Text] [Related]
59. Prominent binding of the dopamine D3 agonist [3H]PD 128907 in the caudate-putamen of the adult rat.
Hillefors M; von Euler M; Hedlund PB; von Euler G
Brain Res; 1999 Mar; 822(1-2):126-31. PubMed ID: 10082890
[TBL] [Abstract][Full Text] [Related]
60. Hypothermic effects of dopamine D3 receptor agonists in the island of Calleja Magna. Potentiation by D1 activation.
Barik S; de Beaurepaire R
Pharmacol Biochem Behav; 1998 Jun; 60(2):313-9. PubMed ID: 9632212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
